TrianglePUBLICATIONS · 28660740
Prolonged first-line PEG-asparaginase treatment in pediatric acute lymphoblastic leukemia in the NOPHO ALL2008 protocol-Pharmacokinetics and antibody formation.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Pediatr Blood Cancer
- Publication date
- 2017 Dec
- First author
- Tram Henriksen L
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Tram Henriksen L
- type
- Author
- name
- Gottschalk Højfeldt S
- type
- Author
- name
- Schmiegelow K
- type
- Author
- name
- Frandsen TL
- type
- Author
- name
- Skov Wehner P
- type
- Author
- name
- Schrøder H
- type
- Author
- name
- Klug Albertsen B
- type
- Author
- name
- Nordic Society of Pediatric Hematology and Oncology, NOPHO Group
- type
- CollectiveName
Complete bibliographic record and source provenance
- authors
- name
- Tram Henriksen L
- type
- Author
- name
- Gottschalk Højfeldt S
- type
- Author
- name
- Schmiegelow K
- type
- Author
- name
- Frandsen TL
- type
- Author
- name
- Skov Wehner P
- type
- Author
- name
- Schrøder H
- type
- Author
- name
- Klug Albertsen B
- type
- Author
- name
- Nordic Society of Pediatric Hematology and Oncology, NOPHO Group
- type
- CollectiveName
- bibliography ids
- nci-bib-fe75e59f0818a1cc3079611c
- book metadata
- content sha256
- a03c1e5e08c72f4948d9c0b006aa2c1deef20be1f8dc75bec49add88b1646f3c
- document type
- citation
- dois
- 10.1002/pbc.26686
- electronic publication date
- display
- 2017 Jun 29
- precision
- day
- year
- 2017
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:28660740
- immutable id
- pubmed:28660740@a03c1e5e08c72f4948d9c0b006aa2c1deef20be1f8dc75bec49add88b1646f3c
- journal
- abbreviation
- Pediatr Blood Cancer
- issn electronic
- 1545-5017
- issn print
- 1545-5009
- issue
- 12
- name
- Pediatric blood & cancer
- nlm unique id
- 101186624
- pages
- Source null
- volume
- 64
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 28660740
- provenance
- batch id
- 1c173f0e18be0c6d461b
- provider
- NCBI PubMed ESummary
- record sha256
- 965dfe622f4118d7c2d482451f6f9dbac81d0bacada02fc9f22250681cc0f9e5
- response sha256
- 27a6f8bb5d49a8d376b07e1b1768913c558986bf73de92cdd65c8f05a5fa1e61
- retrieved at
- 2026-09-09T23:47:25.975513+00:00
- publication date
- display
- 2017 Dec
- precision
- month
- year
- 2017
- publication types
- Journal Article
- Randomized Controlled Trial
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Prolonged first-line PEG-asparaginase treatment in pediatric acute lymphoblastic leukemia in the NOPHO ALL2008 protocol-Pharmacokinetics and antibody formation.
Preserved source evidence · Not medical advice